AzTrials
AzTrials

Down SyndromeNCT02882698

Performance Analysis in Down Syndrome on Mobile Phone

A study testing Down Syndrome Group 1, Down Syndrome Group 2 and Typical Development Group 1 in people with Down Syndrome, run by University of Sao Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The game Marble Maze Classic® will be used, in which the participants have to move the mobile phone to conduct a virtual marble through a maze design. The investigators will evaluate 100 individuals (50 with Down Syndrome-DS and 50 with typical development-TD) and divide both with DS and TD into group 1 and 2, where… Read more about this study

Who is it for?
Ages 11 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Down Syndrome
What is being tested?
Down Syndrome Group 1, Down Syndrome Group 2 and Typical Development Group 1
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteBrazil
Study dates
Sep 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • diagnosis of DS;
  • ability to perform a gripping movement to hold the mobile phone with one of the hands.

Who cannot join

  • presence of comorbidities such as autism or other associated genetic alterations;
  • functional disability that impedes the execution of the task or failure of task comprehension after five attempts carried out during the familiarization phase.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Associacao de Pais e Amigos dos Excepcionais de Amparo (APAE)

    Amparo, São Paulo, 13905-010

Other trials in Brazil

About this study

Official title: Performance Analysis in Down Syndrome Through a Maze Game on Mobile Phone

The game Marble Maze Classic® will be used, in which the participants have to move the mobile phone to conduct a virtual marble through a maze design. The investigators will evaluate 100 individuals (50 with Down Syndrome-DS and 50 with typical development-TD) and divide both with DS and TD into group 1 and 2, where each group consists of 25 participants, with group 2 using a maze design totally opposite to group 1.

Read the detailed description

The game Marble Maze Classic® will be used, in which the participants have to move the mobile phone to conduct a virtual marble through a maze design. The investigators will evaluate 100 individuals (50 with Down Syndrome-DS and 50 with typical development-TD) and divide both with DS and TD into group 1 and 2, where each group consists of 25 participants, with group 2 using a maze design totally opposite to group 1.

Participants from both SD and TD will be divided into two subgroups: Group 1 (n = 50, consisting of 25 participants in TD and 25 participants in SD) and Group 2 (n = 50, consisting 25 participants in TD and 25 participants in SD), with the design of the maze for group 2 totally opposite to that of group 1 in all stages of the experiment. The use of opposite mazes is necessary to verify that the sequence of movements of the maze path does not influence performance.

To maintain the characteristics of random sampling, where each participant has an equal chance to participate in the groups, The investigators used simple probabilistic random sampling, by conducting the drawing on paper.

PROCEDURES

Individuals will be positioned comfortably in a chair set according to the size necessary, as well as a footrest, so as to stay properly positioned to enable the execution of the task.

Before starting the task, the functioning of the game will be verbally explained, along with a demonstration made by the examiner. The examiner will state that the goal of the game is to get the marble to the end of the maze in the shortest possible time through movements up, down and sideways (supination and pronation of the forearm, flexion and extension of the wrist and fingers). Participants will perform all attempts with the dominant hand (except in intermanual transfer phase) and this task will be repeated several times according to the design of the experiment. In each experiment phase (acquisition, retention and transfer) the execution time will be noted of the entire path from the beginning of the maze until the end point, and in each phase this path has to be performed by a specific amount of repetitions.

To try to match the difficulty of the task, the mazes are customized with paths that require eight basic movements for the virtual marble to reach the target, with two movements of forearm pronation, two supination, two wrist flexion and two extension.

In the design of the learning protocol, the participants have to perform 30 repetitions of the maze task for the acquisition phase with the dominant hand, each group with their own maze. After these 30 repetitions, there was a 5-minute rest period in which the participant is not in contact with the task. Then, 5 repetitions will be performed in the retention phase with the same maze acquisition. For the transfer phase, the participants will perform 15 repetitions divided into 3 blocks of 5 attempts using different maze designs:

  • Transfer A: a maze with the path in a different layout to the acquisition (five repetitions);
  • Transfer B: the same acquisition maze, however carried out with non-dominant hand (five repetitions);
  • Transfer 3: the same acquisition maze with the start-end point of the path reversed (five repetitions).
Conditions
Down Syndrome
Being tested
Down Syndrome Group 1, Down Syndrome Group 2, Typical Development Group 1, Typical Development Group 2
Keywords
Down syndrome, motor skills, physiotherapy, mobile telephone, exposure to virtual reality therapy
Medical subject headings
Down Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Down Syndrome Group 1Behavioural

    Acquisition and retention phase on maze A, transfer on maze B and C.

  • Down Syndrome Group 2Behavioural

    Acquisition and retention phase on maze C, transfer on maze A and B.

  • Typical Development Group 1Behavioural

    Control group. Acquisition and retention phase on maze A, transfer on maze B and C.

  • Typical Development Group 2Behavioural

    Control group. Acquisition and retention phase on maze C, transfer on maze A and B.

Study groups in NCT02882698
Study groupRoleWhat they receive
Down Syndrome Group 1ExperimentalAcquisition and retention phase on maze A, transfer on maze B and C.
Receives: Behavioral: Down Syndrome Group 1
Down Syndrome Group 2ExperimentalAcquisition and retention phase on maze C, transfer on maze A and B.
Receives: Behavioral: Down Syndrome Group 2
Typical Development Group 1Active comparatorControl group. Acquisition and retention phase on maze A, transfer on maze B and C.
Receives: Behavioral: Typical Development Group 1
Typical Development Group 2Active comparatorControl group. Acquisition and retention phase on maze C, transfer on maze A and B.
Receives: Behavioral: Typical Development Group 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement of performance

    that individuals with DS would be able to adapt to the virtual task using the mobile phone and improve performance with practice in acquisition, as well as maintain the performance in transfer tasks, namely, to change the maze.

    Measured: Up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionNov 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02882698
Sponsor's protocol ID
341/1
Status last verified
Apr 2017
First submitted
18 Aug 2016
Last updated
11 Apr 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Down Syndrome Group 1, Down Syndrome Group 2 and Typical Development Group 1 in people with Down Syndrome, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement of performance (time frame: Up to 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in